Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Pharmaceutical Research
|
July 4, 2008
Targets in fibrotic disorders
R J Kok
Journal of Chromatography. B, Biomedical Sciences and Applications
|
May 23, 1997
Bioanalysis of captopril: two sensitive high-performance liquid chromatographic methods with pre- or postcolumn fluorescent labeling
R J Kok, J Visser, F Moolenaar, et al.
Renal Failure
|
May 9, 1998
Drug delivery to the kidneys and the bladder with the low molecular weight protein lysozyme
R J Kok, M Haas, F Moolenaar, et al.
Advanced Drug Delivery Reviews
|
August 20, 2010
Drug targeting to the kidney: Advances in the active targeting of therapeutics to proximal tubular cells
M E M Dolman, S Harmsen, G Storm, et al.
International Journal of Pharmaceutics
|
December 2, 2023
3D-printed prednisolone phosphate suppositories with tunable dose and rapid release for the treatment of inflammatory bowel disease
L I Kocabas, S Ayyoubi, M Tajqurishi, et al.
International Journal of Pharmaceutics
|
February 15, 2026
A highly absorbing substrate based on functionalized calcium carbonate for personalized dosing of clonidine by drop-on dispensing
T Lashkari, W E Hennink, S M Hassanizadeh, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 23, 1998
Specific delivery of captopril to the kidney with the prodrug captopril-lysozyme
R J Kok, F Grijpstra, R B Walthuis, et al.
Analytica Chimica Acta
|
June 8, 2011
Characterization of drug-lysozyme conjugates by sheathless capillary electrophoresis-time-of-flight mass spectrometry
R Haselberg, S Harmsen, M E M Dolman, et al.
International Journal of Pharmaceutics
|
February 1, 2015
Formulation and characterization of microspheres loaded with imatinib for sustained delivery
F Ramazani, W Chen, C F Van Nostrum, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 23, 2002
Targeting of captopril to the kidney reduces renal angiotensin-converting enzyme activity without affecting systemic blood pressure
R J Kok, R F G Haverdings, F Grijpstra, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Pharmaceutical Research
|
July 4, 2008
Targets in fibrotic disorders
R J Kok
Journal of Chromatography. B, Biomedical Sciences and Applications
|
May 23, 1997
Bioanalysis of captopril: two sensitive high-performance liquid chromatographic methods with pre- or postcolumn fluorescent labeling
R J Kok, J Visser, F Moolenaar, et al.
Renal Failure
|
May 9, 1998
Drug delivery to the kidneys and the bladder with the low molecular weight protein lysozyme
R J Kok, M Haas, F Moolenaar, et al.
Advanced Drug Delivery Reviews
|
August 20, 2010
Drug targeting to the kidney: Advances in the active targeting of therapeutics to proximal tubular cells
M E M Dolman, S Harmsen, G Storm, et al.
International Journal of Pharmaceutics
|
December 2, 2023
3D-printed prednisolone phosphate suppositories with tunable dose and rapid release for the treatment of inflammatory bowel disease
L I Kocabas, S Ayyoubi, M Tajqurishi, et al.
International Journal of Pharmaceutics
|
February 15, 2026
A highly absorbing substrate based on functionalized calcium carbonate for personalized dosing of clonidine by drop-on dispensing
T Lashkari, W E Hennink, S M Hassanizadeh, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 23, 1998
Specific delivery of captopril to the kidney with the prodrug captopril-lysozyme
R J Kok, F Grijpstra, R B Walthuis, et al.
Analytica Chimica Acta
|
June 8, 2011
Characterization of drug-lysozyme conjugates by sheathless capillary electrophoresis-time-of-flight mass spectrometry
R Haselberg, S Harmsen, M E M Dolman, et al.
International Journal of Pharmaceutics
|
February 1, 2015
Formulation and characterization of microspheres loaded with imatinib for sustained delivery
F Ramazani, W Chen, C F Van Nostrum, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 23, 2002
Targeting of captopril to the kidney reduces renal angiotensin-converting enzyme activity without affecting systemic blood pressure
R J Kok, R F G Haverdings, F Grijpstra, et al.
Page
of 3